The pharmaceutical distribution channel operates on razor-thin margins of 8-12%, where dealer retention directly impacts market penetration and brand equity. TagnPay's loyalty infrastructure addresses a critical gap: 73% of pharma dealers lack structured protection mechanisms while competing on price alone. Our platform transforms transactional relationships into strategic partnerships by embedding insurance and protection benefits into reward architectures, enabling dealers to build sustainable competitive advantages. With 450+ pharmaceutical enterprises already leveraging our technology, we've engineered a category-first solution that decouples dealer profitability from inventory velocity through multi-dimensional loyalty mechanics.
See ChannelLoyalty in Action
15-minute personalized demo with a channel loyalty specialist.
The Industry Challenge
Gaps in Existing Solutions
Strategic Framework
Platform Architecture
End-to-end B2B Channel Loyalty + Rewards + AI Analytics
B2B Channel Ecosystem
Different layers need different reward logic & engagement frequency. ChannelLoyalty maps the complete distribution hierarchy.
Each layer connects to the ChannelLoyalty Mobile App + WhatsApp for engagement
Align every layer. Reward every behavior. Measure every outcome.
Get a Customized Loyalty Solution for Your Industry
Our channel loyalty experts will design a tailored program architecture, reward structure, and ROI projection for your specific business context.
Industry Use Case
PharmaBrand, a ₹850cr pharmaceutical company with 3,200 dealer network across North & Central India, faced 18% annual dealer attrition and ₹4.2cr inventory shrinkage. They deployed TagnPay's hybrid loyalty-insurance platform with three-tier dealer segmentation: Premium (5% cash + inventory insurance), Standard (3% cash + loss protection), and Growth (2% cash + performance bonus). Within 90 days, dealer activation reached 87% through WhatsApp-first enrollment. By month six, program-enrolled dealers showed 34% higher order frequency, 41% reduction in documented shrinkage, and zero insurance claim disputes. Brand switching declined from 18% to 4% annually. PharmaBrand achieved 4.8x ROI through increased dealer loyalty value rather than margin compression, and their dealer Net Promoter Score improved from 32 to 58.
Frequently Asked Questions
Request a Customized Proposal
Our loyalty architects will design a program blueprint tailored to your industry and channel structure.